Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700034077

Trial Profile

Clinical Trials Insight: 700034077

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 30 May 2008

At a glance

  • Drugs Bevacizumab; Carboplatin; Dulanermin; Paclitaxel
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 30 May 2008 New trial record.
    • 16 May 2008 Interim results will be presented at ASCO in May.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top